WILMINGTON — DuPont has agreed to sell its Kevlar and Nomex business to Arclin for $1.8 billion in a bid to slim down the company before it faces the future as “new DuPont.”

The Delaware legacy company announced late Friday afternoon that it entered into a definitive agreement to sell its Aramids business to Arclin which is backed by private investment firm TJC.

Through the deal, DuPont will receive $1.2 billion cash and a note receivable of $300 million, indicating that the payment will be made at a later date. DuPont will also receive non-controlling interest at the future Arclin company valued at $325 million, or at 17.5% stake in the company. The deal is expected to close in the first quarter of 2026.

DuPont reports that the Aramids division had 1,900 employees between five manu

See Full Page